MENU

Published on 16/09/2020 9:03:18 AM | Source: Religare Broking Ltd

Buy Dabur India Ltd For Target Rs. 616 - Religare Broking

Posted in Broking Firm Views - Short Term Report| #Dabur India Ltd #Trading Report #Religare Broking Ltd

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel  https://t.me/InvestmentGuruIndia 

Download Telegram App before Joining the Channel

Investment Pick - Dabur India Ltd.

* Dabur India Ltd is a leading packaged consumer products manufacturer offering a wide range of products based on traditional Ayurveda and Nature. The company’s business is divided among three verticals like Health care (HC), Home and Personal Care (HPC) and Foods. Further, it has portfolio of nearly 400+ products, out of which it has eight distinct power brands such as Dabur Amla, Dabur Chyawanprash, Dabur Honey, Honitus, Pudin Hara, Dabur Lal Tail, Real and Vatika which have gained popularity across the globe.

* We believe Dabur, a leading Ayurveda and natural product maker company is well placed in this segment as increasing demand and changing consumer’s preference towards ayurvedic & natural products have helped the company to gradually expand its product portfolio and maintain market share. Further for next 1-2 years the company’s focus would be on investing behind its core brand, increasing innovation across ayurvedic products in both domestic and international markets, strengthening distribution channel and improving operating efficiencies. Besides, the company has strong balance sheet and has well maintained its liquidity flow. Therefore we remain positive on the company’s long term growth plans and thus we have initiated a BUY on the stock with a target price of Rs 616, an upside of 21.3%.

Buy Dabur India Ltd @ 9-12 Months CMP 505.75 TGT 616

 

To Read Complete Report & Disclaimer Click Here

 

Please refer disclaimer http://ex.religareonline.com/disclaimer

SEBI Registration number is INZ000174330

 

Above views are of the author and not of the website kindly read disclaimer